Rainbow Accelerates Investment in Annex II Defending and Annex III in EU
The EU is one of the major markets in Rainbow’s strategic plan.
The company decided to invest about 50 million Euros over the next five years, to screen for important active ingredients and to invest in Annex II Defending & Annex III for marketable formulations in the EU market. At the same time, Rainbow does not rule out the acquisition of EU localization companies in order to speed up the access to the EU market.
Since 2016, Rainbow has been investing in pesticide technical equivalences in the European Union. It has now obtained the equivalent identification of about 30 active components in the EU, and more than 50 AIs are in progress. This is a major step in building Rainbow’s One Stop Technical Material Supply Platform for the EU market.
It is expected that the continuous increase of investment in the EU market will lay a solid foundation for Rainbow’s sustained growth in 2025-2030.